The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.

Almroth, H

The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events. [electronic resource] - Journal of internal medicine Sep 2011 - 281-90 p. digital

Publication Type: Journal Article

1365-2796

10.1111/j.1365-2796.2011.02395.x doi


Aged
Anti-Arrhythmia Agents--administration & dosage
Arrhythmias, Cardiac--chemically induced
Atrial Fibrillation--complications
Cardiovascular Agents--therapeutic use
Cohort Studies
Comorbidity
Death, Sudden, Cardiac--epidemiology
Female
Flecainide--administration & dosage
Humans
Incidence
Male
Middle Aged
Patient Selection
Research Design
Retrospective Studies
Risk Factors
Sweden--epidemiology